Validating an Amharic version of the 36-Item Short Form Health Survey (SF-36) in individuals with leprosy in Ethiopia

IF 0.8 4区 医学 Q4 DERMATOLOGY Leprosy review Pub Date : 2023-03-01 DOI:10.47276/lr.94.1.53
Saba Maria Lambert, Shimelis Nigusse, Digafe Alembo, Stephen Walker, Peter Nicholls, Diana Nancy Lockwood
{"title":"Validating an Amharic version of the 36-Item Short Form Health Survey (SF-36) in individuals with leprosy in Ethiopia","authors":"Saba Maria Lambert, Shimelis Nigusse, Digafe Alembo, Stephen Walker, Peter Nicholls, Diana Nancy Lockwood","doi":"10.47276/lr.94.1.53","DOIUrl":null,"url":null,"abstract":"Background Health-related quality of life (HRQoL) has now become an indispensable outcome measure in many randomized clinical trials and other studies. It provides the patient’s voice in measuring health improvement or decline and assessing treatment effectiveness. A validated Amharic version of HRQoL assessment tool was needed for leprosy clinical trials in Ethiopia. The SF-36 was chosen but a validated Amharic version was not available. We describe how this was developed. Methods The SF-36 was translated from English into Amharic and evaluated for content acceptability in a patient focus group. Back translation was performed. Validity and reliability of the Amharic SF-36 in leprosy affected individuals was tested with 100 patients with leprosy attending the leprosy clinic at ALERT hospital and compared to the Amharic version of the WHOQOL-BREF. Results Amharic versions of both the WHOQOL-BREF and the SF-36 had good reliability and validity amongst leprosy affected individuals. Internal consistency reliability estimates for each domain/scale exceeded 0.70. The Amharic SF-36 had better convergent and discriminant validity than WHOQOL-BREF in this group of patients. Good known-group validity was seen in both WHOQOL-BREF and SF-36 in leprosy affected patients. The Amharic SF-36 had good inter-rater reliability with seven out of 8 domains scoring above 0.8 in intra-class correlation. Conclusion This Amharic version of the SF-36 is a valid instrument to measure HRQoL in studies and clinical settings involving leprosy affected individuals in Ethiopia.","PeriodicalId":18196,"journal":{"name":"Leprosy review","volume":"13 1","pages":"0"},"PeriodicalIF":0.8000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leprosy review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47276/lr.94.1.53","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background Health-related quality of life (HRQoL) has now become an indispensable outcome measure in many randomized clinical trials and other studies. It provides the patient’s voice in measuring health improvement or decline and assessing treatment effectiveness. A validated Amharic version of HRQoL assessment tool was needed for leprosy clinical trials in Ethiopia. The SF-36 was chosen but a validated Amharic version was not available. We describe how this was developed. Methods The SF-36 was translated from English into Amharic and evaluated for content acceptability in a patient focus group. Back translation was performed. Validity and reliability of the Amharic SF-36 in leprosy affected individuals was tested with 100 patients with leprosy attending the leprosy clinic at ALERT hospital and compared to the Amharic version of the WHOQOL-BREF. Results Amharic versions of both the WHOQOL-BREF and the SF-36 had good reliability and validity amongst leprosy affected individuals. Internal consistency reliability estimates for each domain/scale exceeded 0.70. The Amharic SF-36 had better convergent and discriminant validity than WHOQOL-BREF in this group of patients. Good known-group validity was seen in both WHOQOL-BREF and SF-36 in leprosy affected patients. The Amharic SF-36 had good inter-rater reliability with seven out of 8 domains scoring above 0.8 in intra-class correlation. Conclusion This Amharic version of the SF-36 is a valid instrument to measure HRQoL in studies and clinical settings involving leprosy affected individuals in Ethiopia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在埃塞俄比亚麻风病患者中验证阿姆哈拉语版本的36项简短健康调查(SF-36)
背景:健康相关生活质量(HRQoL)已成为许多随机临床试验和其他研究中不可或缺的结果测量指标。它为衡量健康状况的改善或下降以及评估治疗效果提供了患者的意见。埃塞俄比亚的麻风病临床试验需要一个经过验证的阿姆哈拉语版本的HRQoL评估工具。SF-36被选中了,但是没有经过验证的阿姆哈拉版本。我们描述了这是如何发展起来的。方法将SF-36从英文翻译成阿姆哈拉语,并在患者焦点组中评估其内容的可接受性。进行反向翻译。对在ALERT医院麻风病诊所就诊的100名麻风病患者进行了阿姆哈拉语SF-36在麻风病患者中的有效性和可靠性测试,并与阿姆哈拉语版本的WHOQOL-BREF进行了比较。结果WHOQOL-BREF和SF-36的阿姆哈拉语版本在麻风人群中具有良好的信度和效度。每个域/尺度的内部一致性可靠性估计超过0.70。Amharic SF-36在本组患者中的收敛效度和判别效度均优于WHOQOL-BREF。在麻风病患者中WHOQOL-BREF和SF-36均有良好的已知组效度。阿姆哈拉语SF-36具有良好的等级间信度,8个域中有7个域的等级内相关得分在0.8以上。结论阿姆哈拉语版本的SF-36是衡量埃塞俄比亚麻风病患者研究和临床环境中HRQoL的有效工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Leprosy review
Leprosy review 医学-病理学
CiteScore
1.10
自引率
16.70%
发文量
35
审稿时长
>12 weeks
期刊介绍: Leprosy Review is an Open Access peer reviewed journal including original papers on all aspects of leprosy. Topics published include research into the medical, physical and social aspects of leprosy and information relevant to leprosy control. We publish original research, short reports, case studies and reviews. The vision of the journal is to improve the management and control of leprosy and its consequences, by publishing relevant research and sharing experiences and best practices.
期刊最新文献
Evaluation of skin temperature in the hands of leprosy patients to detect peripheral autonomic dysfunction, by infrared thermography Why we need to continue to target field workers and healthcare providers at the primary level to prevent visual loss in leprosy Dapsone induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, sparing leprosy patches as an ‘anatopic’ response: A case report An uncommon manifestation of a not-so-common disease: A Sweet dilemma Money matters: Priorities in leprosy research funding
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1